Canadian Implantable Defibrillator Study (CIDS)
To evaluate Implantable Cardioverter Defibrillator against Amiodarone
The primary outcome measure was all-cause mortality, and the secondary outcome was arrhythmic death.
Number of Patients
Number of Sites
Number of Countries
- Connolly SJ1, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O’Brien B. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000 Mar 21;101(11):1297-302.